Neurocrine Biosciences agreed to buy Soleno Therapeutics for $2.9 billion in a move intended to expand its endocrinology and rare-disease portfolio.
Source link
Neurocrine to Buy Soleno for $2.9 Billion
Date:
More like thisRelated
Climate extremes fuel explosive wildfires in Canada and the U.S., experts say
The United States is burning...
Albuquerque officials break ground on new path for bikers and walkers
ALBUQUERQUE, N.M. (KRQE) – Albuquerque city officials held a special...